A history of the discovery of bacteriophages. Will the well - forgotten old become new?
Staphylococcus is considered to be one of the most common pathogens that can lead to the development of numerous pathological processes, from pyoderma to peritonitis. Being a potentially pathogenic microorganism, it is able not to make itself noticed for years, peacefully coexisting with the host organism. But should one only go through a viral infection out of bed, suffer from stressful situations, or simply get overcooled, the potentially pathogenic microflora activates and manifests itself as a local or general infectious process. Activation of staphylococcal microflora is most often observed in sickly people with weakened immune systems, suffering from endocrine diseases, having long ellneses. Long-term and uncontrolled use of antibiotics with the formation of resistance to them is also of great importance. It is the widespread distribution of antibiotic-resistant strains of staphylococcus that makes doctors and scientists look for new forms of controling this and other microorganisms. Against this background, it’s time to recall the bacteriophages long forgotten in the era of the craze for antibiotics, especially given the fact that over the past thirty years not a single completely new group of antibacterial agents has been synthesized.